Interpace Biosciences, Inc. (IDXG) — SC 13G/A Filings
All SC 13G/A filings from Interpace Biosciences, Inc.. Browse 1 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (1)
-
Douglas M. Singer Amends Interpace Biosciences Stake
— Feb 12, 2024 Risk: low
Douglas M. Singer, an individual investor, has filed an amended Schedule 13G/A for Interpace Biosciences, Inc. (NASDAQ: IDXG), indicating his beneficial ownersh
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX